Management of acute exacerbations in multiple sclerosis
- PMID: 20182574
- PMCID: PMC2824954
- DOI: 10.4103/0972-2327.58283
Management of acute exacerbations in multiple sclerosis
Abstract
A key component of multiple sclerosis is the occurrence of episodes of clinical worsening with either new symptoms or an increase in older symptoms over a few days or weeks. These are known as exacerbations of multiple sclerosis. In this review, we summarize the pathophysiology and treatment of exacerbations and describe how they are related to the overall management of this disease.
Keywords: Exacerbation; management; multiple sclerosis; relapse; steroids.
Conflict of interest statement
Similar articles
-
Self reported stressful life events and exacerbations in multiple sclerosis: prospective study.BMJ. 2003 Sep 20;327(7416):646. doi: 10.1136/bmj.327.7416.646. BMJ. 2003. PMID: 14500435 Free PMC article.
-
[Therapeutic indications for acute episodes of multiple sclerosis].Rev Neurol (Paris). 2001 Sep;157(8-9 Pt 2):988-95. Rev Neurol (Paris). 2001. PMID: 11787365 Review. French.
-
Acute Multiple Sclerosis Relapse.Continuum (Minneap Minn). 2016 Jun;22(3):799-814. doi: 10.1212/CON.0000000000000330. Continuum (Minneap Minn). 2016. PMID: 27261683 Review.
-
Practical management problems of chronic obstructive pulmonary disease in the elderly: acute exacerbations.Curr Opin Pulm Med. 2011 Dec;17 Suppl 1:S49-54. doi: 10.1097/01.mcp.0000410748.28582.22. Curr Opin Pulm Med. 2011. PMID: 22209931 Review.
-
[Influence of acute aggravations on the development of long-term handicap in relapsing remitting multiple sclerosis: a clinical study in 99 patients].Rev Neurol (Paris). 2007 Jan;163(1):72-81. doi: 10.1016/s0035-3787(07)90357-4. Rev Neurol (Paris). 2007. PMID: 17304175 French.
Cited by
-
Anti-inflammatory and Neuroprotective Agents in Clinical Trials for CNS Disease and Injury: Where Do We Go From Here?Front Immunol. 2020 Sep 10;11:2021. doi: 10.3389/fimmu.2020.02021. eCollection 2020. Front Immunol. 2020. PMID: 33013859 Free PMC article. Review.
-
Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses.J Neuroinflammation. 2022 Sep 7;19(1):220. doi: 10.1186/s12974-022-02583-y. J Neuroinflammation. 2022. PMID: 36071461 Free PMC article.
-
Amnion-Derived Multipotent Progenitor Cells Suppress Experimental Optic Neuritis and Myelitis.Neurotherapeutics. 2021 Jan;18(1):448-459. doi: 10.1007/s13311-020-00949-9. Epub 2020 Oct 16. Neurotherapeutics. 2021. PMID: 33067748 Free PMC article.
-
Immunomodulatory Aspects of Therapeutic Plasma Exchange in Neurological Disorders-A Pilot Study.Int J Mol Sci. 2023 Mar 31;24(7):6552. doi: 10.3390/ijms24076552. Int J Mol Sci. 2023. PMID: 37047524 Free PMC article.
-
VBP15, a novel anti-inflammatory, is effective at reducing the severity of murine experimental autoimmune encephalomyelitis.Cell Mol Neurobiol. 2015 Apr;35(3):377-387. doi: 10.1007/s10571-014-0133-y. Epub 2014 Nov 13. Cell Mol Neurobiol. 2015. PMID: 25392236 Free PMC article.
References
-
- Compston A, Coles A. Multiple sclerosis. Lancet. 2008;37264:1502–17. - PubMed
-
- Lublin FD. The incomplete nature of multiple sclerosis relapse resolution. J Neurol Sci. 2007;256:S14–8. - PubMed
-
- Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J, et al. The natural history of multiple sclerosis: A geographically based study: 2: Predictive value of the early clinical course. Brain. 1989;112:1419–28. - PubMed
-
- Schumacker GA, Beebe G, Kibler RF, Kurland LT, Kurtzke JF, McDowell F, et al. Problems of experimental trials of therapy in multiple sclerosis: Report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci. 1965;122:552–68. - PubMed
-
- Wingerchuk DM, Rodriguez M. Premenstrual multiple sclerosis pseudoexacerbations: Role of body temperature and prevention with aspirin. Arch Neurol. 2006;63:1005–8. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources